Citation only
via Europe PMC
T1-weighted/T2-weighted ratio reflects microstructural changes in Alzheimer's disease.
Reijner N, Ramos MR, Jacobs E, Toen DV, Tijms B, Rozemuller AJM, van der Weerd L, Barkhof F, van de Berg WDJ, Jonkman LE.
Alzheimer's research & therapy · 2026
Abstract
<h4>Background</h4>The T1-weighted/T2-weighted ratio (T1w/T2w-ratio) has been considered as a relatively simple neuroimaging approach to map myelin content in the aging and diseased brain. However, we hypothesize that any process affecting the tissue microstructural integrity also contributes to observed changes in the T1w/T2w-ratio. Here, we aim to evaluate the ability of T1w/T2w-ratio to detect microstructural changes, specifically within the paradigm of Alzheimer's disease (AD).<h4>Methods</h4>Postmortem in-situ T1-weighted and T2-weighted MRI scans of 27 control and 51 AD brain donors were processed into standardized T1w/T2w-ratio images and parcellated into cortical regions according to the brainnetome atlas. Using an identical pipeline, antemortem MRI scans of 9 AD cases were processed. Immunohistochemical staining and digital quantification were performed for amyloid-beta (4G8), phosphorylated tau (AT8), neuro-axonal damage (NfL), myelin (PLP), microglia (IBA1), and iron (Meguro) in 9 cortical regions. Data was analysed using linear mixed models.<h4>Results</h4>Whole cortex T1w/T2w-ratio was 15% lower in AD compared to controls and was 13% lower in the hippocampus of typical AD compared to atypical AD clinical phenotypes. Additionally, a strong correlation was found between antemortem and postmortem T1w/T2w-ratios (r = 0.85). Whole-brain associations between T1w/T2w-ratio and histological changes were found in both control and AD patients: T1w/T2w-ratio associated with myelin density (Controls: β = 0.229; AD: β = 0.312) and microglia density (Controls: β=-0.090; AD: β=-0.496). In AD but not in controls, T1w/T2w-ratio associated with amyloid-beta (β = 0.233), phosphorylated tau (β=-0.220), and neuro-axonal damage (β = 0.170). Iron load showed contrasting associations in controls and AD (Controls: β=-0.359; AD: β = 0.154).<h4>Conclusion</h4>The findings in this study suggest that the T1w/T2w-ratio is mainly associated with myelin density in healthy controls, but is a broader indicator of microstructural integrity in Alzheimer's disease, where it additionally largely associates with accumulation of amyloid-beta, phosphorylated tau and neuro-axonal damage. Therefore, the T1w/T2w-ratio is not a myelin-specific marker in AD, but could be a valuable neuroimaging tool for tracking longitudinal microstructural changes when interpreted alongside established AD pathology biomarkers.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1186/s13195-026-02093-6
- Canonical
- link ↗
- Fetched
- 2026-07-02 MST
Cite this
APA
N, R., MR, R., E, J., DV, T., B, T., AJM, R., L, V.D.W., F, B., WDJ, V.D.B., & LE., J. (2026). T1-weighted/T2-weighted ratio reflects microstructural changes in Alzheimer's disease. <em>Alzheimer's research & therapy</em>. https://doi.org/10.1186/s13195-026-02093-6
Vancouver
N R, MR R, E J, DV T, B T, AJM R, et al. T1-weighted/T2-weighted ratio reflects microstructural changes in Alzheimer's disease. Alzheimer's research & therapy. 2026. doi:10.1186/s13195-026-02093-6.
BibTeX
@article{reijner2026Tweigh,
title = {T1-weighted/T2-weighted ratio reflects microstructural changes in Alzheimer's disease.},
author = {Reijner N and Ramos MR and Jacobs E and Toen DV and Tijms B and Rozemuller AJM and van der Weerd L and Barkhof F and van de Berg WDJ and Jonkman LE.},
journal = {Alzheimer's research & therapy},
year = {2026},
doi = {10.1186/s13195-026-02093-6},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PLoS Medicine 2018
Open access · CC-BY
Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study
Brain Behavior and Immunity 2019
Open access · CC-BY
Transcriptomic analysis of probable asymptomatic and symptomatic alzheimer brains
Phytotherapy research : PTR 2026
Open access · OA
Microglial Activation Under Hypoxic Conditions in Early Alzheimer's Disease: Can Natural SIRT1 Activators Be Therapeutic Allies in the Inflammation-Energy Axis?
PLoS ONE 2020
Open access · CC-BY
Performance of diagnostic and predictive host blood transcriptomic signatures for Tuberculosis disease: A systematic review and meta-analysis
Aging Cell 2020
Open access · CC-BY
The inherited methylome landscape is directly altered with paternal aging and associated with offspring neurodevelopmental disorders
Molecular Ecology 2020
Citation only